Longeveron LGVN
NASDAQ LGVN
$1.59 +0.16 (+11.19%)
At close: Oct 22, 2026 · 4:00 PM EDT

Longeveron (LGVN) Current Debt (2020 - 2021)

Updated

Longeveron's Current Debt came in at -$38,000 for FY2021, compared with -$25,000 in FY2020.

Analysis

Longeveron (LGVN) Current Debt (2020 - 2021) Analysis & Trends

  • Per Business Quant, earlier years put Current Debt at -$25,000 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Debt (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 3.51 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn -4.36 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn -
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn -
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 208.00 Mn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn -
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn -
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn -
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn 64.00 Mn
10 Longeveron 4.81 Mn -34.99 Mn 182,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 -19,000.00
Mar 31, 2021 -19,000.00
Dec 31, 2020 -83,000.00
API Access

Longeveron Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-debt&ticker=LGVN&period=max&api_key=YOUR_API_KEY